Bristol-Myers plans biologics manufacturing facility in Ireland


US pharma major Bristol-Myers Squibb plans to construct a new state-of-the-art, large-scale biologics…

BiotechnologyBristol-Myers SquibbIrelandProduction

Bristol-Myers Squibb and Samsung BioLogics expand manufacturing deal


US drug major Bristol-Myers Squibb and South Korea’s Samsung BioLogics revealed that they will increase…

Asia-PacificBiotechnologyBristol-Myers SquibbProductionSamsung BioLogics

Brazil to produce atazanavir to supply SUS demand; strong pharma growth forecast for 2014


Following the Official Gazette market application filling for the drug atazanavir sulfate, an HIV protease…

Anti-viralsatazanavirBrazilBristol-Myers SquibbFiocruzGenericsMarkets & MarketingPharmaceuticalProductionSouth America

Bristol-Myers partners with South Korean firm on biopharma production


US pharma major Bristol-Myers Squibb (NYSE: BMY) has entered into a 10-year agreement under which Samsung…

Asia-PacificBiotechnologyBristol-Myers SquibbOncologyPharmaceuticalProductionSamsung BioLogics

Bristol-Myers pumps about $250 million into biologics facility expansion


Just a few days after announcing the closure of its biotech subsidiary Amylin facility in California…

BiotechnologyBristol-Myers SquibbFinancialPharmaceuticalProductionResearch

Back to top